TBCRC 058: A randomized phase II study of enzalutamide, enzalutamide with mifepristone, and treatment of physician’s choice in patients with androgen receptor-positive metastatic triple-negative or estrogen receptor-low breast cancer (NCT06099769).

Authors: Tiffany A. Traina, Yuan Chen, Katia Khoury, Hope S. Rugo, Erica L. Mayer, Yara Abdou, Michelle E. Melisko, Fresia Pareja, Britta Weigelt, Sarat Chandarlapaty, Nicholas C. Turner, Joshua Michael Lang, Marina Nasrin Sharifi, Suzanne Daniela Conzen, Rita Nanda

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps1142

Source: Full article

---

Abstract

TPS1142